Our mission is to continuously provide the highest level of expertise, and the highest quality of integrated and innovative research services for pre-clinical evaluation, accelerating your oncology target’s time to market.

Business Model
Crown Biosciences’ business model is built on our commitment to building a comprehensive drug development service company. We will do this by :

• building the largest collection of xenograft and human primary models,

• hiring expertise to provide comprehensive capabilities for preclinical evaluation

• investing in capacity, to ensure the most cost efficient infrastructures

• provide the highest level of quality of data and project management , raising the bar in the CRO market space.

• fast turnaround times from target to market by offering a complete preclinical service capability in each project team of experts.